Molecular testing, frequency of molecular alterations and targeted 1st-line treatment of patients with non-small cell lung carcinoma in Germany. Results from the prospective German Registry CRISP (AIO-TRK-0315) 18. Februar 2019 Griesinger, F., Eberhardt, W.E.E., Nusch, A., Reiser, M., Zahn, M.O., Marschner, N., Jaenicke, M., Fleitz, A., Spring, L., Sahlmann, J., Karatas, A., Hipper, A., Weichert, W., Rittmeyer, A., Christopoulos, P., Waller, C.F., Sebastian, M., Thomas, M., 2019. Pneumologie 2019; 73(S 01) DOI: 10.1055/s-0039-1678074 Results from a prospective real world study show strong efficacy of idelalisib in CLL, including high-risk CLL, and provide evidence that PJP prophylaxis positively impacts on overall survival. Hoechstetter, M., Eissmann, P., Hucke, N., van Troostenburg, A., Ramroth, H., Knauf, W., 2018. Blood 132 (suppl 1), 4428. https://doi.org/10.1182/blood-2018-99-112843… Weiterlesen Daten vertikal transportieren im Data Step: Implizites und explizites Retain und seine Alternativen. Sahlmann, J., Scheiner-Sparna, R., 2018. In: Christel Weiß, Ralf Minkenberg und Rainer Muche (Hg.): KSFE 2018. Proceedings der 22. KSFE Tagung. Shaker Verlag, Aachen, pp. Weiterlesen